Filing Details

Accession Number:
0001181431-11-011588
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-02-18 18:25:27
Reporting Period:
2011-02-16
Filing Date:
2011-02-18
Accepted Time:
2011-02-18 18:25:27
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1427925 Acelrx Pharmaceuticals Inc ACRX Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1113520 Three Arch Associates Iii Lp C/O Three Arch Partners
3200 Alpine Road
Portola Valley CA 94028
No No Yes No
1190472 A Mark Wan C/O Three Arch Partners
3200 Alpine Rd
Portola Valley CA 94028
Yes No No No
1190474 E Wilfred Jaeger C/O Three Arch Partners
3200 Alpine Rd
Portola Valley CA 94028
No No Yes No
1256738 Three Arch Management Iii Llc 3200 Alpine Road
Portola Valley CA 94028
No No Yes No
1256741 Three Arch Partners Iii Lp No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2011-02-16 31,357 $0.00 31,357 No 4 C Indirect See Footnote
Common Stock Acquisiton 2011-02-16 583,255 $0.00 583,255 No 4 C Indirect See Footnote
Common Stock Acquisiton 2011-02-16 25,106 $0.00 56,463 No 4 C Indirect See Footnote
Common Stock Acquisiton 2011-02-16 466,990 $0.00 1,050,245 No 4 C Indirect See Footnote
Common Stock Acquisiton 2011-02-16 44,702 $0.00 101,165 No 4 C Indirect See Footnote
Common Stock Acquisiton 2011-02-16 831,466 $0.00 1,881,711 No 4 C Indirect See Footnote
Common Stock Acquisiton 2011-02-16 27,142 $0.00 128,307 No 4 C Indirect See Footnote
Common Stock Acquisiton 2011-02-16 504,860 $0.00 2,386,571 No 4 C Indirect See Footnote
Common Stock Acquisiton 2011-02-16 1,430 $0.00 129,737 No 4 C Indirect See Footnote
Common Stock Acquisiton 2011-02-16 26,615 $0.00 2,413,186 No 4 C Indirect See Footnote
Common Stock Acquisiton 2011-02-16 65,806 $5.00 195,543 No 4 P Indirect See Footnote
Common Stock Acquisiton 2011-02-16 1,223,983 $5.00 3,637,169 No 4 P Indirect See Footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 C Indirect See Footnote
No 4 C Indirect See Footnote
No 4 C Indirect See Footnote
No 4 C Indirect See Footnote
No 4 C Indirect See Footnote
No 4 C Indirect See Footnote
No 4 C Indirect See Footnote
No 4 C Indirect See Footnote
No 4 C Indirect See Footnote
No 4 C Indirect See Footnote
No 4 P Indirect See Footnote
No 4 P Indirect See Footnote
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Series A Convertible Preferred Stock Disposition 2011-02-16 22,959 $0.00 31,357 $0.00
Common Stock Series A Convertible Preferred Stock Disposition 2011-02-16 427,040 $0.00 583,255 $0.00
Common Stock Series B Convertible Preferred Stock Disposition 2011-02-16 16,741 $0.00 25,106 $0.00
Common Stock Series B Convertible Preferred Stock Disposition 2011-02-16 311,384 $0.00 466,990 $0.00
Common Stock Series C Convertible Preferred Stock Disposition 2011-02-16 44,702 $0.00 44,702 $0.00
Common Stock Series C Convertible Preferred Stock Disposition 2011-02-16 831,466 $0.00 831,466 $0.00
Common Stock Convertible Promissory Note Disposition 2011-02-16 0 $0.00 24,608 $0.00
Common Stock Convertible Promissory Note Disposition 2011-02-16 0 $0.00 457,716 $0.00
Series C Preferred Stock Warrant to purchase Series C Convertible Preferred Stock Disposition 2011-02-16 6,135 $0.00 6,135 $0.00
Common Stock Series C Convertible Preferred Stock Acquisiton 2011-02-16 6,135 $0.00 6,135 $0.00
Common Stock Series C Convertible Preferred Stock Disposition 2011-02-16 4,838 $0.00 4,838 $5.00
Common Stock Series C Convertible Preferred Stock Disposition 2011-02-16 1,297 $0.00 1,297 $0.00
Series C Preferred Stock Warrant to purchase Series C Convertible Preferred Stock Disposition 2011-02-16 114,123 $0.00 114,123 $0.00
Common Stock Series C Convertible Preferred Stock Acquisiton 2011-02-16 114,123 $0.00 114,123 $0.00
Common Stock Series C Convertible Preferred Stock Disposition 2011-02-16 89,993 $0.00 89,993 $5.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 C Indirect
0 No 4 C Indirect
0 No 4 C Indirect
0 No 4 C Indirect
0 No 4 C Indirect
0 No 4 C Indirect
0 No 4 C Indirect
0 No 4 C Indirect
0 No 4 X Indirect
6,135 No 4 X Indirect
1,297 No 4 S Indirect
0 No 4 C Indirect
0 No 4 X Indirect
114,123 No 4 X Indirect
24,130 No 4 S Indirect
Footnotes
  1. The shares reflect the automatic conversion of 22,959 shares of the Issuer's Series A Convertible Preferred Stock for 31,357 shares of the Issuer's Common Stock immediately prior to the closing of the Issuer's initial public offering.
  2. The shares are held by Three Arch Associates III, L.P. The voting and dispositive decisions with respect to the shares held by Three Arch Associates III, L.P., are made by the following Managing Members of its general partner Three Arch Management III, L.L.C.: Mark Wan and Wilfred Jaeger, each of whom disclaims beneficial ownership of such shares.
  3. The shares reflect the automatic conversion of 427,040 shares of the Issuer's Series A Convertible Preferred Stock for 583,255 shares of the Issuer's Common Stock immediately prior to the closing of the Issuer's initial public offering.
  4. The shares are held by Three Arch Partners III, L.P. The voting and dispositive decisions with respect to the shares held by Three Arch Partners III, L.P., are made by the following Managing Members of its general partner Three Arch Management III, L.L.C.: Mark Wan and Wilfred Jaeger, each of whom disclaims beneficial ownership of such shares.
  5. The shares reflect the automatic conversion of 16,741 shares of the Issuer's Series B Convertible Preferred Stock for 25,106 shares of the Issuer's Common Stock immediately prior to the closing of the Issuer's initial public offering.
  6. The shares reflect the automatic conversion of 311,384 shares of the Issuer's Series B Convertible Preferred Stock for 466,990 shares of the Issuer's Common Stock immediately prior to the closing of the Issuer's initial public offering.
  7. The shares reflect the automatic conversion of shares of the Issuer's Series C Convertible Preferred Stock into Common Stock on a one-for-one basis upon the closing of the Issuer's initial public offering.
  8. Notes and accrued interest in the aggregate of $108,572.10 converted automatically upon the closing of the Issuer's initial public offering into shares of Common Stock at a conversion price of $4.00, which is 80.0% of the per share price of the Common Stock sold in the Issuer's initial public offering.
  9. Notes and accrued interest in the aggregate of $2,019,445.02 converted automatically upon the closing of the Issuer's initial public offering into shares of Common Stock at a conversion price of $4.00, which is 80.0% of the per share price of the Common Stock sold in the Issuer's initial public offering.
  10. Immediately convertible into shares of the Issuer's Common Stock.
  11. These shares have no expiration date.
  12. A note with the principal amount plus accrued interest of $98,433.72 converted automatically upon the closing of the Issuer's initial public offering into shares of Common Stock at a conversion price of $4.00 which is of 80.0% of the per share price of the Common Stock sold in the Issuer's initial public offering.
  13. A note with the principal amount plus accrued interest of $1,830,866.97 converted automatically upon the closing of the Issuer's initial public offering into shares of Common Stock at a conversion price of $4.00 which is 80.0% of the per share price of the Common Stock sold in the Issuer's initial public offering.
  14. The exercise price is $3.942 per share.
  15. Immediately exercisable prior to and contingent upon the closing of the Issuer's initial public offering.
  16. Pursuant to its terms, the warrant was to be terminated at the closing of the Issuer's initial public offering. Holder elected to net exercise the warrants immediately prior to the closing of the Issuer's initial public offering. In the event the Issuer's public offering did not occur, the warrant would have terminated on September 14, 2017, unless earlier terminated in accordance with its terms, in a liquidation or change of control transaction.
  17. These shares represent the net exercise of a warrant to purchase Series C Convertible Preferred Stock for an acquisition of 1,297 shares of Series C Convertible Preferred Stock of the Issuer.
  18. These shares represent the net exercise of a warrant to purchase Series C Convertible Preferred Stock for an acquisition of 24,130 shares of Series C Convertible Preferred Stock of the Issuer.